NCT04697498

Brief Summary

Improving the anesthesiology management for surgical correction of spinal deformations with introducing the diagnostic methods and treatment strategy of acute pain, preventing the evolution of chronic pain. Development and implementation in clinical practice perioperative intensive care protocols for surgical correction of spinal deformities.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 16, 2020

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

December 29, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 6, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

5 years

First QC Date

December 29, 2020

Last Update Submit

October 4, 2023

Conditions

Keywords

Erector spinae plane blockRegional anesthesiaScoliosisSpinal DeformityMultimodal analgesia

Outcome Measures

Primary Outcomes (3)

  • Change in The Numeric Pain Rating Scale

    The 11-point numeric scale ranges from '0' representing one pain extreme - "no pain"; to '10' representing the other pain extreme - "pain as bad as you can imagine" or "worst pain imaginable". Will be measured in rest and in the movement.

    On the 1st, 2rd and 3th day after surgery

  • Duration of hospitalization

    Through study completion, an average of 1 year

  • Time of weaning the patient from mechanical ventilation

    From a few minutes to an hour

Secondary Outcomes (17)

  • The amount of opioid administered during surgery and in the postoperative period

    Through study completion, an average of 1 year

  • Mechanical pain threshold and sensitivity

    Baseline, on the 1st, 3rd and 5th day after surgery

  • Overall satisfaction with analgesia will be assessed on a 5-point Likert scale

    Through study completion, an average of 1 year

  • Level of postoperative sedation will be assessed with Richmond Agitation-Sedation Scale

    On the 1st day after surgery

  • In the group of patients which will undergo general anaesthesia with Erector spine plane block, anaesthetised dermatomes will be counted along the paravertebral, scapular, anterior, middle and posterior axillary, midclavicular and parasternal lines

    Baseline, 1st day after surgery

  • +12 more secondary outcomes

Study Arms (2)

The Control Group

ACTIVE COMPARATOR

The control group will include patients who will undergo surgery under general anesthesia.

Procedure: General anaesthesia

The Study Group

EXPERIMENTAL

The study group will include patients who will undergo surgery under general anesthesia using a bilateral bi-level Erector spine plane block.

Procedure: Bilateral bi-level Erector spine plane block

Interventions

After intubation of the trachea and rotation on the abdomen before the skin incision will be performed bilateral bi-level Erector spine plane block. Before surgery, the level of screw placement will be discussed with the surgeon, and the blockade will be performed at two levels of the spine bilaterally as close as possible to the screw placement site. For blockade a solution for prolonged blockade of peripheral nerve plexuses with bupivacaine 0.375%, dexamethasone 0.02% and epinephrine 0.00018% will be used.

The Study Group

The control group - will include patients who will undergo surgery under general anaesthesia

The Control Group

Eligibility Criteria

Age12 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent of the patient or his legal representatives to participate the study.
  • Spinal deformity that requires surgical correction.
  • No known allergies to local anaesthetics.
  • Negative intradermal test for sensitivity to local anaesthetics.

You may not qualify if:

  • Refusal of the patient or his legal representatives to participate the study
  • Diabetes mellitus, known allergy to local anaesthetics
  • Acute spinal cord injury
  • Physical status according to classification ASA III and more
  • A positive intradermal test for sensitivity to a local anaesthetic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rivne Oblast State Hospital

Rivne, Rivne Oblast, 33000, Ukraine

RECRUITING

Related Links

MeSH Terms

Conditions

ScoliosisAcute PainChronic PainPain, PostoperativeHyperalgesiaIntraoperative ComplicationsBlood Loss, SurgicalHemostatic DisordersPostoperative Nausea and VomitingPostoperative Cognitive ComplicationsNeuralgiaNutrition DisordersVentilator-Induced Lung Injury

Interventions

Anesthesia, General

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesSomatosensory DisordersSensation DisordersNervous System DiseasesHemorrhageVascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesNauseaSigns and Symptoms, DigestiveVomitingCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental DisordersPeripheral Nervous System DiseasesNeuromuscular DiseasesNutritional and Metabolic DiseasesLung InjuryLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • Maksym Barsa

    Rivne Region Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 29, 2020

First Posted

January 6, 2021

Study Start

December 16, 2020

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

October 5, 2023

Record last verified: 2023-10

Locations